Krystal Biotech, Inc. (KRYS)

Krystal Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,259	4,506	3,499	2,040	1,742	1,182
Market Cap Growth	-5.78%	28.76%	71.56%	17.08%	47.34%	23.36%
Enterprise Value	4,448	3,819	2,909	1,642	1,388	899
Last Close Price	181.69	156.66	124.06	79.22	69.95	60.00
PE Ratio	37.04	50.54	320.10	-	-	-
Forward PE	29.63	33.31	-	-	-	-
PS Ratio	14.57	15.51	69.02	-	-	-
PB Ratio	5.05	4.76	4.49	3.91	2.94	4.05
P/TBV Ratio	5.05	4.76	4.49	3.91	2.94	4.05
P/FCF Ratio	28.36	37.81	-	-	-	-
P/OCF Ratio	26.91	36.51	-	-	-	-
EV/Sales Ratio	12.38	13.15	57.38	-	-	-
EV/EBITDA Ratio	29.04	36.14	-	-	-	-
EV/EBIT Ratio	29.30	37.01	-	-	-	-
EV/FCF Ratio	23.98	32.04	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.06	0.07	-	-	-	-
Debt / FCF Ratio	0.05	0.06	-	-	-	-
Asset Turnover	0.35	0.31	0.07	-	-	-
Inventory Turnover	1.10	1.20	-	-	-	-
Quick Ratio	9.13	6.89	17.35	13.14	17.02	17.56
Current Ratio	9.68	7.28	17.77	13.30	17.18	17.80
Return on Equity (ROE)	15.61%	10.34%	1.68%	-25.09%	-15.71%	-13.00%
Return on Assets (ROA)	9.23%	6.88%	-8.83%	-12.80%	-9.32%	-7.93%
Return on Capital (ROIC)	10.00%	7.41%	-9.22%	-13.38%	-9.73%	-8.21%
Return on Capital Employed (ROCE)	14.40%	10.80%	-	-	-	-
Earnings Yield	2.79%	1.98%	0.31%	-6.86%	-3.99%	-2.72%
FCF Yield	3.53%	2.65%	-2.88%	-7.53%	-6.67%	-3.46%
Buyback Yield / Dilution	-1.66%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q